Pneumococcal Polysaccharide Vaccine (PPSV23) (Nursing)

00:01 Now let's talk about the pneumococcal polysaccharide vaccine.

00:05 Doctors give a single dose of this vaccine to people who need it.

00:09 There are some additional recommendations from the CDC for people with chronic medical conditions.

00:16 Now, I've got a whole list for you there, but I know you're pretty familiar with what chronic medical conditions are.

00:22 But no, generally doctors give a single dose.

00:26 But if the patient has a chronic medical condition like we have listed there for you, they may need an additional one or two more doses.

00:35 I know I'm giving you lots of information but take a look at this, the pneumococcal polysaccharide vaccine actually helps protect against twenty three types of pneumococcal bacteria.

00:48 Now look back in your notes at the conjugate vaccine.

00:51 Is this more or less than the conjugate vaccine? You got it. It's more.

00:58 Now it doesn't come without side effects.

01:00 They'll have some mild problems following a pneumococcal polysaccharide vaccination.

01:05 So we're looking for reactions where the site was given some redness, some pain, but this should be mild.

01:12 The patient can also develop fever or aching muscles.

01:16 These problems should be fairly mild and go away within about two days.

01:20 If they persist, the patient needs to contact their health care provider.

01:26 Wow, I hate to even get into this topic.

01:28 But remember, the point of this video is to educate you so you can make an informed decision.

01:34 So we're going to talk about it because we have to.

01:37 We're talking about the effectiveness of vaccines.

01:40 Now, I'm not going to deal an opinion because I know there are plenty of them out there, okay? So I'm going to deal with numbers from the research studies from the CDC.

01:51 So studies show that for each patient who received one dose of pneumococcal conjugate vaccine, here's what we see as far as impacting people developing that type of infection.

02:03 80% fewer babies will develop pneumococcal infection.

02:07 75% fewer patients aged 65 years or older will contract invasive pneumococcal disease.

02:15 And 45 percent fewer patients who are 65 years or older will contract pneumococcal pneumonia.

02:23 So pause for just a minute.

02:25 I don't think you want to memorize these numbers but those are some pretty amazing statistics of how much lower the infection rate can be from this particular vaccine.

02:37 Now, let's look at the pneumococcal polysaccharide vaccine, same thing, one dose, between 50 to 85% of a healthy adults will not develop invasive pneumococcal disease if they received the pneumococcal polysaccharide vaccine.